Jay Bhimani

This 👂 podcast episode and insight’s from a16z Bio + Health's Julie Yoo spoke so clearly to the fundamental challenge facing both 🩺 clinicians and 🏥 healthcare systems.  There is a huge disconnect between supply, in the availability of clinicians, and demand, in the increasing volume and complexity of healthcare needs. -     36% of physicians plan to reduce their hours next year according to the AMA -     48% of physicians reported feeling burned out in a 2024 Medscape survey At the same time, the demographic baby boomer bubble and steady increase in the prevalence of major chronic disease, which consumes up to 90% of healthcare expenditures according to some estimates, is driving demand. With this context, Yoo points to a major opportunity for AI adoption in healthcare in 2025. Yeah, a VC hyping a wave of new AI companies that will replace the decades of training and experience of clinicians, the skeptic would say.  But Yoo is thoughtful in pointing to the role AI can play, and is already playing, through solutions such as ambient, autonomous scribe solutions (of which local star Abridge is leading the pack) in not replacing, but freeing up productivity for clinicians. There is so much unstructured context in both the complexity of disease and treatment options and the social/emotional considerations that we shouldn't be looking for AI to *replace* clinicians. But companies are getting better at finding the structured, repetitive and time-consuming places where AI tools can *help* clinicians. Nearly two-thirds of doctors cited bureaucratic tasks as the leading contributor to burnout. Rigorously trained-AI driven solutions can be a force multiplier for clinicians, and I’ve seen several interviews where nurses and doctors go as far as to say some of these solutions are ”restoring their joy in practicing medicine”. Our health is precious; and we rightly want any technology engaging with it to be developed thoughtfully and thoroughly tested. This requires top AI talent and diverse and realistic training data. Pittsburgh’s strengths in both areas is why we are an emerging hub for data-driven healthcare. #AIinhealthcare #clinicianburnout #healthinnovation #digitalhealth

15

This is quite incredible to see. Very few #CMMI demonstrations can point to any savings at all. And “…MSSP savings go further than savings generated by Medicare Advantage…” #ACO #VBP #Primarycare #MSSP #healthcareinnovation

1

🎥 Exciting update: I recently joined Jody Tropeano Greene to discuss the DiMe Seal, a milestone in building trust and accountability in digital health. Check out our conversation here: https://lnkd.in/epMHYU5x 🌟 Launched at HLTH 2024, the DiMe Seal recognizes high-quality, trustworthy digital health software products. Since its debut, we’ve seen incredible momentum: 🏥 Healthcare systems and payers across the US are looking to the DiMe Seal to help de-risk their digital health software purchases 🌍 Digital health software developers across the world are recognizing the value of the DiMe Seal to distinguish their products in a crowded market 👉 Are you a developer of digital health software products? Pursue the DiMe Seal and join the leaders setting the standard for quality and trust in healthcare innovation. Register today and use the code HLTH25 for a 25% discount https://lnkd.in/eTb6rRbj Let’s continue to raise the bar for digital health together! 🚀 #DigitalHealth #DiMeSeal #HLTH2024 #Innovation #TrustInHealth

72

5 Comments

I always read Rock Health's digital health reports as they give a nice pulse feel for what is happening in the digital health funding space. Good to see funds raised in H1 2024 suggest funding in the sector seems to have stabilized at 2023 levels. Its no surprise the report emphasis the buzz around AI and healthcare. There have been clear winners in the AI healthcare space in the area of process and cost optimization and the R&D space. The impact of AI in care and treatment delivery is so far much more muted. One area I never though to look at AI was in its ability to bring together multiple healthcare pathways and digital point solutions into a more holistic seamless experience for the patient. There is a clear trend away from using stand alone digital health point solutions, and could AI address this challenge by facilitating the efficient integration of disparate processes and technology into unified care programs. I can see this happening with digital health products but this will be more tricky to do with physical care programs involving clinicians and HCPs. “AI is helping us combine multiple parts of the care journey, across all care experiences. In the future, benefits navigation, clinical guidance, and care delivery won’t be delivered by separate companies or point solutions within the healthcare ecosystem. They’ll be features that work in concert within products, and they’ll happen in under 90 seconds for a seamless patient experience.” – Glen Tullman, CEO, Transcarent and Managing Partner, 7wireVentures

11

Thank you Saul Marquez for being on "This Week in Pharmacy" --TWIRx In this insightful episode, we sit down with Saul Marquez, veteran of Medtronic and the visionary founder and CEO of Outcomes Rocket, a #podcast and company dedicated to improving healthcare outcomes and driving business success. Outcomes Rocket is a unique shared knowledge hub that brings together healthcare leaders, non-healthcare operators, and investors to discuss and solve pressing healthcare challenges. Key Discussion Points: About Outcomes Rocket: Saul explains how Outcomes Rocket started as a podcast and evolved into a company with a mission to connect healthcare leaders, share best practices, and break down industry silos. By focusing on collaboration and knowledge-sharing, Outcomes Rocket aims to transform healthcare into a more efficient and patient-centered industry. The Power of Connection: Saul dives into how Outcomes Rocket connects healthcare silos, enabling leaders to share knowledge and improve outcomes. By fostering collaboration across the industry, Outcomes Rocket helps bridge gaps and drive positive change in healthcare delivery. Join us as we explore how Saul Marquez and Outcomes Rocket are making a significant impact in the healthcare landscape by fostering a community of leaders committed to improving care and business success. Whether you're a healthcare professional, investor, or entrepreneur, this episode will provide valuable insights into the power of connection and collaboration in healthcare. YouTube Interview here: https://lnkd.in/eEXXRyTz

11

1 Comment

🙋‍♂️ 🙋‍♀️ How is Health Connect South impacting the Healthcare & Life Sciences ecosystem? I had the pleasure of interviewing Mike Mosquito, CHCIO, MBA, PMP, CDH-E, Bradley Dick , Kelsey Mayo , Khan Siddiqui, MD , and Andy Miller on this topic. Check out what they had to say! Thanks Russ Lipari for a great event!

13

1 Comment

Q2 2024 saw a resurgence in home-based care M&A, driven by strategic acquisitions and a cautious yet optimistic private equity landscape. Based on the Q2 2024 Home-Based Care M&A Report from Mertz Taggart, here are the top three trends that I see: 1. Increased Deal Activity: After a slow first quarter, M&A activity picked up significantly, particularly in home health and hospice sectors. 2. Private Equity Influence: Private equity’s role in M&A was smaller than usual due to tightened credit markets, but optimism is rising for more deals in the latter half of 2024. 3. Strategic Acquisitions: Companies like Addus and Amedisys made strategic moves to expand their market share, signaling continued consolidation in the industry. As deal activity heats up, how will these trends shape the future of home care? You can read the full report here - https://hubs.ly/Q02KY4r90 #HomeCare #MergersAndAcquisitions #HealthcareTrends

12

1 Comment

Peter Birch from Talking HealthTech and I get down to the nitty-gritty of why 2025 might be the year of healthcare #interoperability.

9

1 Comment

Health tech companies reported strong Q3 2024 earnings, driven by expanded offerings, rapid adoption of AI tools, and increased client demand. Here’s a recap of key updates: - Hims & Hers: A telehealth platform offering personalized treatments across mental health, sexual health, dermatology, primary care, and weight management. Q3 revenue jumped 77% to $401.6M, net income was $75.6M, and subscribers grew 44% to 2M. The company plans to launch a generic liraglutide in 2025 and raised its 2024 revenue forecast to $1.46B-$1.465B. - Doximity: A networking and workflow platform for medical professionals providing tools like telehealth, scheduling, and AI assistants. Revenue increased 20% to $136.8M, with AI tools leading growth and 1M prompts used in Q2. The company raised its 2024 guidance to $535M-$540M in revenue. - Waystar: A healthcare payment and revenue cycle management company serving 30,000+ clients across care settings. Revenue grew 22% to $240M, driven by rapid client adoption after a competitor’s cyberattack. The company raised 2024 revenue guidance to $926M-$934M and expects 2025 revenue near $1B.

2

I'm thrilled that today, we announced a significant milestone for Clover Health: the launch of Counterpart Health. Our innovative Clover Assistant (CA) platform is now available to all Medicare Advantage payors and providers under the new brand name Counterpart Assistant. Why am I so excited about this? This move is a strategic leap forward in our mission to improve healthcare for everyone. With Counterpart Assistant, we're not just expanding our reach—we're leveraging cutting-edge AI and machine learning capabilities that have already proven to make a real difference in patient care. The healthcare landscape is evolving rapidly, and the need for advanced, data-driven tools has never been greater. Medicare Advantage plans, in particular, are under pressure to improve patient outcomes while managing costs. That’s where Counterpart Assistant comes in. By bringing our technology to more providers, we're empowering clinicians with the tools they need to deliver high-quality, personalized care. What makes Counterpart Assistant special? First, we’re broadening our impact by allowing providers outside of Clover Health's Medicare Advantage plan to benefit from our technology. Our hybrid SaaS and shared-savings model aligns financial incentives with health outcomes, ensuring flexibility and scalability. CA’s AI-driven insights enhance clinical decision-making, and are associated with earlier diagnosis and better management of chronic diseases. Plus, we've built a robust support system to ensure seamless integration and ongoing assistance for all users. Clinicians using CA have seen significant improvements in Medical Cost Ratios and patient outcomes. The timing couldn't be better. The healthcare industry is ripe for transformation, and our technology is poised to lead the way. By expanding the use of Counterpart Assistant, we’re not just keeping up with the changes—we’re driving them. Join us on this exciting journey. Visit our website for more details. Thank you for your continued support as we strive to bring high-quality healthcare to everyone on Medicare. #HealthcareInnovation #AI #MedicareAdvantage #ValueBasedCare #CloverHealth

576

37 Comments

The #digitalhealth train keeps rolling in Q3 2024 but these insights from Rock Health’s latest trends recap are worth amplifying “TAPESTRIES - It’s about creating robust integrated solutions that can serve healthcare’s biggest players” “QUALITY NOT QUANTITY - Investors are making fewer more focused bets” We (NextGen Healthcare) agree. As healthcare stakeholders, especially ambulatory and acute practices remain relentlessly focused on #efficiency and #ROI, solutions that deliver real, measurable impact at scale will continue to lead the way.

17

1 Comment

🥊 A Tough Quarter for CVS – What's Next? 🚨 💊 CVS was the final "Big Six Payor" to reports earnings last Wednesday and I was able to dive into CVS's latest earnings report, and it's clear that the healthcare giant is facing some significant challenges. From Medicare Advantage headwinds to Medicaid acuity issues, CVS is navigating a complex landscape that’s testing Karen Lynch as she has moved to actively manage Aetna. 🗞 In this article, I break down: - The driving forces behind CVS’s Q2 performance and loss of free cash flow along with expanding expenses - Insights into their Medicare Advantage and Medicaid strategies headed into 2025 - The impact of the retail pharmacy contraction and biosimilar partnerships for Cordavis as they look to control the potentially 100 billion dollar market against Cigna and UNH If you’re following the healthcare industry, especially the dynamics among the “Big Six Payors,” subscribe below. CVS Reports Q2 Earnings jeffdelverne.substack.com I'd love to hear your thoughts on CVS’s current trajectory. Do you think they can successfully integrate Aetna, Signify, Oak Street, and Cordavis to turn things around? #healthcare #pharmacy

20

1 Comment

Transcarent is acquiring Accolade for $621M, a 110% premium on its stock price, with the deal expected to close in Q2. The acquisition aims to combine Transcarent's AI-powered health navigation and care solutions with Accolade's healthcare advocacy, expert medical opinions, and primary care services. The combined platform will serve over 1,400 employer and payer clients, focusing on an improved personalized experience, health outcomes, and cost efficiency.

3

👍 In the first half of 2024, U.S. digital health startups secured $5.7 billion across 266 deals, showing a strong rebound after years of slowed investment, according to Rock Health. With early-stage deals driving the momentum, the sector is on track to surpass funding totals from 2019 and 2023. https://bit.ly/4cCRy2W Via Healthcare Dive #digitalhealth #digitalhealthfunding

10

1 Comment

The recent downsizing of VBC operations by giants like Walmart, Walgreens, and CVS marks a pivotal moment in the healthcare sector. This shift from a previous era of aggressive expansion to a more measured approach in scaling value-based care (VBC) reflects a maturing market that prioritizes sustainable growth over size. However, the contraction of these clinics doesn't signal a decrease in the viability of VBC models. In fact, top-performing Accountable Care Organizations (ACOs) continue to prove the profitability of focusing on primary care. These ACOs excel by strategically targeting practices that manage sick yet stable patients—those who are most manageable within a VBC framework and are crucial for consistent shared savings. The success formula is clear: select practices with the right patient demographics and ensure alignment with local specialists and hospitals ready to embrace collaborative, value-driven care. Maximizing risk scores and focusing on preventing care cost escalations in these targeted patient populations are essential tactics. As we move forward, let's consider these shifts as strategic realignments rather than setbacks. For those of us dedicated to transforming healthcare, it's a reminder to remain adaptable, data-driven, and patient-centered in our approaches.

4

What you won’t find: Wheel powering any of the sketchy DTC GLP-1 compounding companies. What you will find: This market exists because companies like Wheel, who prioritize clinical quality and regulatory compliance in every process and product, refuse to take shortcuts. We're committed to ensuring that patients receive high-quality care—not just drive quick profits. Sometimes, choosing ethics over revenue means we don't see a short-term windfall during a "Gold Rush." But as CEO, I can assure you that it also means that patients, customers, and clinicians can trust that Wheel is always on the right side of history. I believe GLP-1s will transform healthcare as profoundly as AI, and Wheel is dedicated to being at the forefront—delivering compliant, accessible, and responsible care.

98

3 Comments

Interesting to see that digital health funding is relatively stable. Only a couple of exits. I think we'll see more deals like DarioHealth's acquisition of Twill, since from a sales perspective, the narrower the solution, the more difficult it is to acquire customers. This difficulty has nothing to do with the quality of offerings, but with the data management and administrative complexity on the customer side.

2

Taking stock of primary care today and looking ahead.... Increasing presence, market share for non-traditional providers - payers, advanced primary care providers, primary care enablers. Question marks over retail's presence in primary care and what care models and patient populations they might need to focus on to be a force. #VBC #populationhealth #primarycare #caremodels

1

1 Comment